From Library Journal
Editor of the Medical Technology Stock Letter since the mid-1980s, McCamant uses his experience to provide a broad and deep overview of this exciting juncture of science and commerce. He focuses on why he thinks, from an investor’s perspective, that now is such a propitious time to get into the market. Chapters cover a history of the field, how to invest, a state-of-the-art summary of biotechnology, patents and the clinical review process, and the future of b…
Buy Biotech Investing: Every Investor’s Guide at Amazon
I picked up this book with two kinds of expectations. One that McCamant would give me the “lay of the land” of the Biotech space, the competing markets and the key companies. The other, that he would provide deep insight (a la Peter Lynch) on an investment method. On the first count, the book does a reasonable job. On the second count, it is very disappointing. Most of the investment rules are obvious and generic. The investment web links are outdated.
Disappointing. I guess this book is one example where the cover says it all; next time I see a book on Biotech investing, I want to see a dollar sign on the jacket.
Sure, I got the biotech bit, but where was the insight into investing. Nothing really hit me. I started reading the book not knowing how to invest in biotech; I ended the same way.
On a positive note, I did like the writing style.